Kiniksa Pharmaceuticals International Plc (KNSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | KNSA | CRSP | LEGN | ||
| Company | Kiniksa Pharmaceuticals International Plc | Crispr Therapeutics Ag | Legend Biotech Corp ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 61.29 | 50.51 | 25.56 | ||
| High | 62.20 | 51.37 | 25.75 | ||
| Low | 60.54 | 49.88 | 22.90 | ||
| Latest | 61.68 | 51.18 | 23.20 | ||
| Change | -0.30 | +0.72 | -2.47 | ||
| % Change | -0.48% | +1.43% | -9.62% | ||
| Volume | 225,932 | 968,660 | 4,326,187 | ||
| 20-Day Average Volume | 1,052,521 | 1,735,689 | 2,530,363 | ||
| Previous Close | 61.98 | 50.46 | 25.67 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 60.77 | 55.02 | 28.54 | ||
| 20-Day Raw Stochastic | 63.41% | 13.24% | 3.20% | ||
| 20-Day Relative Strength | 56.70 | 45.35 | 37.13 | ||
| Weighted Alpha | +90.11 | -20.04 | -36.90 | ||
| Today's Opinion | 100% Buy | 48% Sell | 8% Sell | ||
| Previous Opinion | 100% Buy | 48% Sell | 24% Buy | ||
| Last Month's Opinion | 88% Buy | 80% Sell | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.02% since 07/08/26 | -13.51% since 07/08/26 | -16.43% since 07/08/26 | ||
| Low | 60.13 on 07/14/26 | 49.33 on 07/14/26 | 22.90 on 07/15/26 | ||
| High | 66.16 on 07/09/26 | 60.50 on 07/09/26 | 28.13 on 07/09/26 | ||
| 1-Month | |||||
| %Chg | +17.52% since 06/15/26 | -2.68% since 06/15/26 | -34.36% since 06/15/26 | ||
| Low | 51.08 on 06/16/26 | 49.33 on 07/14/26 | 22.90 on 07/15/26 | ||
| High | 67.53 on 07/07/26 | 63.45 on 07/06/26 | 35.22 on 06/16/26 | ||
| 3-Month | |||||
| %Chg | +34.04% since 04/15/26 | -9.80% since 04/15/26 | +13.50% since 04/15/26 | ||
| Low | 41.49 on 04/21/26 | 46.92 on 05/19/26 | 20.33 on 04/16/26 | ||
| High | 67.53 on 07/07/26 | 63.45 on 07/06/26 | 37.50 on 06/03/26 | ||
| 6-Month | |||||
| %Chg | +62.21% since 01/15/26 | -5.55% since 01/15/26 | +5.34% since 01/15/26 | ||
| Low | 38.04 on 01/16/26 | 44.12 on 03/30/26 | 16.24 on 02/04/26 | ||
| High | 67.53 on 07/07/26 | 63.45 on 07/06/26 | 37.50 on 06/03/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,768,618 | 4,866,816 | 4,767,946 | ||
| Shares Outstanding, K | 76,938 | 96,449 | 185,740 | ||
| Annual Sales | 677,560,000 | 3,510,000 | 1,028,900,000 | ||
| Annual Net Income | 59,010,000 | -581,600,000 | -296,800,000 | ||
| Last Quarter Sales | 214,270,000 | 1,460,000 | 305,100,000 | ||
| Last Quarter Net Income | 22,590,000 | -122,930,000 | -54,300,000 | ||
| 60-Month Beta | 0.07 | 1.71 | 0.34 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.27 on 04/28/26 | -1.28 on 05/04/26 | -0.15 on 05/12/26 | ||
| Earnings Date | 08/04/26 | 08/03/26 | 08/10/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 67.71 | 0.00 | 0.00 | ||